GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codon AG (HAM:CNW) » Definitions » Common Stock

Codon AG (HAM:CNW) Common Stock : €26.72 Mil (As of Jun. 2022)


View and export this data going back to 1990. Start your Free Trial

What is Codon AG Common Stock?

Codon AG's quarterly common stock declined from Jun. 2021 (€43.73 Mil) to Dec. 2021 (€26.72 Mil) but then stayed the same from Dec. 2021 (€26.72 Mil) to Jun. 2022 (€26.72 Mil).

Codon AG's annual common stock increased from Dec. 2019 (€24.30 Mil) to Dec. 2020 (€43.73 Mil) but then declined from Dec. 2020 (€43.73 Mil) to Dec. 2021 (€26.72 Mil).


Codon AG Common Stock Historical Data

The historical data trend for Codon AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codon AG Common Stock Chart

Codon AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.42 19.98 24.30 43.73 26.72

Codon AG Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.42 43.73 43.73 26.72 26.72

Codon AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Codon AG (HAM:CNW) Business Description

Traded in Other Exchanges
N/A
Address
Warthestrasse 21, Teltow, DEU, 14513
Codon AG develops, produces and distributes autologous cell therapies for the minimally invasive repair of cartilage defects. The product being marketed is a cell therapy product for the minimally invasive treatment of cartilage damage in the knee joint that uses only the patient's own cartilage cells (autologous chondrocytes). CODON's method is currently used in over 200 clinics in Germany and more than 14,000 patients have already been treated.